A Study of the Safety of REN001 in Patients With Primary Mitochondrial Myopathy
Clinical trial NCT03862846 · TERMINATED
Trial details
- NCT number
- NCT03862846
- Sponsor
- Reneo Pharma Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-10
- Primary completion
- 2020-04-23
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.